Skip to main content
Erschienen in: Brain Structure and Function 3/2024

Open Access 08.02.2024 | Original Article

Characterization of Sonic Hedgehog transcripts in the adult mouse brain: co-expression with neuronal and oligodendroglial markers

verfasst von: Mariagiovanna Russo, Giuliana Pellegrino, Hélène Faure, Linda Tirou, Ariane Sharif, Martial Ruat

Erschienen in: Brain Structure and Function | Ausgabe 3/2024

Abstract

In the adult mammalian brain, astrocytes are proposed to be the major Sonic Hedgehog (Shh)-responsive cells. However, the sources of the Shh molecule mediating activation of the pathway are still poorly characterized. The present work investigates the distribution and phenotype of cells expressing Shh mRNA in the adult mouse brain. Using single-molecule fluorescent in situ hybridization (smfISH), we report much broader expression of Shh transcripts in almost all brain regions than originally reported. We identify Shh mRNA in HuC/D+ neuronal populations, including GABAergic (glutamic acid decarboxylase 67, Gad67), cholinergic (choline acetyltransferase, ChAT), dopaminergic (tyrosine hydroxylase, TH), nitrergic (neuronal nitric oxide synthase, nNOS), and in a small population of oligodendroglial cells expressing Sox10 and Olig2 mRNA transcription factors. Further analysis of Shh mRNA in cerebral cortical and hypothalamic neurons suggests that Shh is also expressed by glutamatergic neurons. Interestingly, we did not observe substantial Desert Hedgehog and Indian Hedgehog mRNA signals, nor Shh signals in S100β+ astrocytes and Iba1+ microglial cells. Collectively, the present work provides the most robust central map of Shh-expressing cells to date and underscores the importance of nitrergic neurons in regulating Shh availability to brain cells. Thus, our study provides a framework for future experiments aimed at better understanding of the functions of Shh signaling in the brain in normal and pathological states, and the characterization of novel regulatory mechanisms of the signaling pathway.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s00429-023-02756-2.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

The early discovery of Sonic Hedgehog (Shh) transcript expression in mature rodent brain neurons (Traiffort et al. 1998, 1999) paved the way for further studies on the role of Shh signaling in the mammalian brain under physiological conditions or during disease (Briscoe and Therond 2013; Ferent et al. 2013b; Alvarez-Buylla and Ihrie 2014; Ruat et al. 2015; Yao et al. 2016; Garcia et al. 2018; Laouarem and Traiffort 2018; Garcia 2021; Laouarem et al. 2021). Studies in rodents have highlighted a primary role for the pathway in regulating neurogenic niches in the subventricular zone of the lateral ventricles (SVZ) and the subgranular zone (SGZ) of the hippocampus, and the status of oligodendroglial progenitors in brain and cortical structures. Positive modulation of the Shh signaling pathway has been proposed as a potential therapeutic approach for Parkinson's disease (Gonzalez-Reyes et al. 2012; Malave et al. 2021) and for demyelinating diseases (Loulier et al. 2006; Ferent et al. 2013b; Porcu et al. 2015; Samanta et al. 2015; Del Giovane et al. 2022). Blocking the pathway by small molecules inhibitors of the GTP-binding protein-coupled receptor Smoothened (Smo) is proposed as an alternative for treating Shh-dependent medulloblastoma, a cerebellar tumor with a poor prognosis in children (Ruat et al. 2014; Swiderska-Syn et al. 2022). Genetic mutations affecting genes associated with Shh signaling are responsible for the developmental diseases such as holoprosencephaly or medulloblastoma (Wolter et al. 1997; Reifenberger et al. 1998; Traiffort et al. 2004; Ruat et al. 2015; Andreu-Cervera et al. 2021).
Shh belongs to a family of secreted morphogens including Desert Hedgehog (Dhh) and Indian Hedgehog (Ihh). These molecules are synthesized as precursors that undergo internal cleavage generating an aminoterminal peptide displaying almost all biological activities of the peptides. Binding of Shh to its receptor Patched (Ptc), a member of the Resistance-Nodulation-Division transporter superfamily, activates Smo (Ruat et al. 2014; Zhang and Beachy 2023). These events result in complex modulation of the zinc-finger transcription factors glioma-associated oncogenes 1–3 (Gli1–3). Shh is widely distributed in rodent brain regions, whereas Dhh and Ihh expression has not been detected (Ruat et al. 2015; Garcia et al. 2018). Astrocytes have been proposed as the primary targets of Shh signaling as they express components of the Shh transduction machinery including Ptc, Smo, and Gli1–3 (Garcia et al. 2010, 2018; Ruat et al. 2015; Allahyari et al. 2019; Hill et al. 2019; Tirou et al. 2021; Wang et al. 2021). However, the discrepancy between the expression of Ptc and Smo transcripts in several brain areas has led to the hypothesis that Ptc may transduce the Shh signal in the absence of Smo and that Smo may be activated by non-canonical mechanisms (Traiffort et al. 1998; Charytoniuk et al. 2002). It has been reported by us and other groups that both Ptc and Smo are expressed in neurons (Alvarez-Buylla and Ihrie 2014; Ruat et al. 2015; Garcia et al. 2018). The initial discovery of cells expressing Shh transcripts using specific digoxigenin-labeled riboprobes in rodent brain (Traiffort et al. 1998) was followed by detailed analysis of cells expressing this marker in mature rodent central nervous system under physiological and pathophysiological conditions. These studies were conducted with Shh-reporter mouse lines, Shh antibodies, or radioactive and cold riboprobes (Traiffort et al. 1998; Traiffort et al. 2001; Charytoniuk et al. 2002; Lai et al. 2003; Machold et al. 2003; Desouza et al. 2011; Ihrie et al. 2011; Eitan et al. 2016; Sanchez and Armstrong 2018; Sanchez et al. 2018; Gonzalez-Reyes et al. 2019; Rivell et al. 2019; Tirou et al. 2020; Tu et al. 2023). Thus, it has been proposed that Shh is synthesized by a subpopulation of GABAergic cells expressing Gad67 in the ventral brain, by a restricted population of cholinergic neurons expressing ChAT in the motor nuclei and in the basal forebrain (Traiffort et al. 1999; Pascual et al. 2005; Ihrie et al. 2011), by cerebral cortical neurons mainly located in layer V of the cerebral cortex (Charytoniuk et al. 2002; Harwell et al. 2012), in dopaminergic neurons of the substantia nigra (Gonzalez-Reyes et al. 2012; Turcato et al. 2022), in a population of hilar cells (McMahon et al. 2003; Gonzalez-Reyes et al. 2019), in some Pomc+ cells of the arcuate nucleus (ARC) and some Mchr1+ cells of the paraventricular nucleus (PVN) in the hypothalamus (Antonellis et al. 2021), and in Purkinje cells of the cerebellum (Traiffort et al. 1998; Wallace 1999; Farmer et al. 2016). Several ventral brain regions, including the hypothalamic and thalamic nuclei, have also been reported to express Shh signaling (Garcia et al. 2010; Antonellis et al. 2021; Tirou et al. 2021). In most of these studies, Shh is expressed by neurons, while Shh expression in astrocytes and microglia has been observed occasionally in physiological conditions (Sanchez and Armstrong 2018); whereas, Shh expression in these cells under pathophysiological conditions required further investigations (Ruat et al. 2015; Yao et al. 2016; Garcia et al. 2018; Laouarem and Traiffort 2018; Garcia 2021).
Recently, we reported broad expression of Shh recognized by the specific monoclonal antibody C9C5 in a subset of mature CC1+ oligodendrocytes (Tirou et al. 2020). We also identified Shh transcripts by single-molecule fluorescent in situ hybridization (smfISH) in a subset of cells expressing the oligodendroglial markers Olig2 and Sox10 mRNA. These results revealed that Shh expression was more extensive than originally reported. Now, we report a much broader expression of Shh transcripts in the mature mouse brain, which occurs in diverse neuronal populations and in a restricted population of oligodendroglial cells. We also identified a new population of neurons co-expressing Shh transcripts and the nitrergic marker nNOS and reported broad expression of Shh transcripts in hypothalamic nuclei, suggesting potential new roles for Shh in the regulation of neural circuits.

Materials and methods

Ethical approval

All animal experiments were performed in accordance with the Council Directive 2010/63EU of the European Parliament and were approved (Project No. 4558) by the French ethic committee.

Mice and tissue preparation

Young adult (2–3 months old) rodent have been used previously for reporting expression of Shh or its signaling components (Ruat et al. 2015; Laouarem et al. 2018; Garcia 2021). Thus, young adult (2–3 months old) C57Bl/6J (Janvier-Labs) were housed grouped and maintained with access to food and water ad libitum. The room had constant temperature (21–22 °C) and a 12:12-h light/dark cycle. Mice were deeply anesthetized with intraperitoneal injection of xylazine 4 mg/kg (Sedaxylan, Chetra) and ketamine 20 mg/kg (Ketalar, Parke-Davis), and were perfused with 4% paraformaldehyde (PFA) in 0.2 M sodium phosphate, pH 7.4. After dissection, brains were post-fixed for 2 h in 4% PFA and cryoprotected in 20% sucrose/PBS waiting for the tissue to sink at the bottom of the tube. The tissues were mounted in Optimal Cutting Temperature (O.C.T.) compound Tissue-Tek (Sakura Finetek), frozen in liquid nitrogen-cooled isopentane and kept at − 80 °C until use. Tissues were allowed to equilibrate to − 20 °C in the cryostat (Leica, CM3050) for ~ 30 min and 14 μm coronal sections were mounted onto SuperFrost® ultra Plus slides (Thermo Scientific), dried for 1–2 h at − 20 °C and stored at − 80 °C for less than three months. Anatomical landmarks were determined using a mouse brain atlas (Paxinos and Franklin 2001).

RNAscope® in situ multiplex fluorescent assay

The RNAscope Multiplex Fluorescent v2 Reagent Kit was used according to the manufacturer’s instructions (Advanced Cell Diagnostics) with minor modifications. Slides were post-fixed in 4% PFA for 30 min, and then washed in sterile PBS (2 × 5 min) followed by dehydration in increasing concentrations of ethanol (50%, 70%, 100%) for 5 min each at room temperature. Then, slides were air-dried for 5 min and incubated for 30 min at 37 °C in a humidified chamber. Sections were then pretreated with hydrogen peroxide (10 min) and antigen retrieval was performed for 15 min at 98 °C. After 5-min drying at room temperature, a hydrophobic barrier was drawn around the brain sections with ImmEdge Pen and they were dried again for 5 min. Sections were treated with RNAscope® Protease Plus, and incubated with hybridization probes and amplifiers. Positive and negative control probes were run in each experiment as an internal control, to assess sample RNA quality and tissue optimal permeabilization. Development of HRP signal with TSA® plus fluorophores was performed exactly as recommended with the dilution indicated in Table S1. Finally, slides were counterstained with RNAscope® Multiplex Fl v2 DAPI. Images were acquired with a 20 × objective using an Axio Imager Z2 ApoTome microscope equipped with a motorized stage (Zeiss, Germany) or a fluorescence microscope Leica DM2000. All images were captured over a defined z-focus range corresponding to visible fluorescence within the section. Negative controls were used to assess the negative control background and to set the signal-to-noise ratio for background levels for each experiments. Positive controls were used to assess the positive control signal strength. Images were analyzed using ZEN software (Zeiss) or LAS-X software (Leica) and reconstructed in ImageJ 1.52p (NIH) using the z-stack module and Photoshop CS3 (Adobe).

Immunohistochemistry

Some sections were subjected to immunohistochemistry after RNAscope and before counterstaining. They were blocked 1 h in PBS, 0.25% Triton-X100, 1% BSA. After washing in PBS pH 7.4 (2 × 5 min), the primary antibodies, detailed in Supplementary Information Table S2, were incubated at 4 °C overnight for anti-S100β and anti-HuC/D or for 2 nights for anti-TH. Next, slices were washed in PBS (3 × 5 min) and incubated with the secondary antibody (1/400, 488-conjugated Donkey, anti-mouse (# R37114) or anti rabbit (#R37118), Invitrogen) for 2 h at room temperature. Finally, slides were washed again in PBS (3 × 5 min) and counterstained with RNAscope® Multiplex Fl v2 DAPI to be analyzed as described above. Association of in situ probes and antibodies is listed in Supplementary Information Table S3 together with sagittal position to bregma of the sections analyzed.

Cell count and analysis

Brain regions were delineated using the Allen Adult Mouse Brain Atlas (http://​atlas.​brain-map.​org/​atlas?​atlas=​602630314#atlas=​602630314&​). The nomenclature used corresponds to the one described in the Paxinos Atlas. The quantification of HuC/D-, Gad67-, nNOS-, and TH-expressing neurons was done by counting the number of single labeled cells in the arcuate (ARC), ventromedial (VMH) and dorsomedial (DMH) hypothalamic nuclei, represented by plate 70 of the Allen Adult Mouse Brain Atlas, and in the substantia nigra compacta (SNc) and ventral tegmental area (VTA), represented by plate 82 of the same Atlas. Cells were counted unilaterally in the ARC, VMH, DMH, SNc and VTA delimited by DAPI nuclear staining from the analysis of one section per adult mouse, N = 3 animals. Between 100 and 170 cells were counted as TH-expressing neurons in the SNc and VTA nuclei. From 100 to 400 HuC/D-expressing cells were counted in the ARC, VMH, and DMH. Between 100 and 200 cells were counted as Gad67-expressing neurons in the ARC and DMH; while from 9 to 18 Gad67-expressing neurons were counted in the VMH, where Gad67 transcript is less expressed. From 100 to 225 nNOS-expressing cells were counted in the VMH and DMH; while 42–48 cells were counted in the ARC where the nNOS transcript is less expressed. Density of Shh mRNA was estimated by RNAscope from one section per adult mouse, N = 3 animals, and scored as follows: 4+: very high density, > 30 dots/cell; 3+: high density, 10–30 dots/cell; 2+: moderate density, 6–9 dots/cell; 1+: low density, 2–5 dots/cell; 0+: undetectable, 0–1 dot/cell. Counting of colocalized staining was undertaken using ROI and multi-point ImageJ tools. Data are represented as the mean ± SEM.

Results

Shh mRNA expression is widespread in the brain, whereas Dhh and Ihh mRNAs are not

We used single-molecule multiplex fluorescent in situ hybridization (smfISH) to study the distribution of Shh, Dhh, and Ihh mRNAs in the adult mouse brain (Fig. 1). We successfully detected consistent and reproducible expression of Shh transcripts using RNAscope in various brain regions (Fig. 1A–C). As shown in Table 1, the cell-associated density of Shh mRNA was assessed from the number of spots counted per nucleus and classified as "very high density," "high density," "moderate density," "low density," and "undetectable." Regions expressing very high density of Shh signals were found in the striatum, pallidum, claustrum, trigeminal mesencephalic and motor nuclei, facial nucleus, and in the Purkinje cell layer of the cerebellum, as previously reported using a digoxigenin-labeled Shh-specific cRNA probe (Traiffort et al. 1998, 1999, 2001). However, most brain regions had cells expressing Shh mRNA at low to moderate or low to high density, whereas fibrous tracts and a few nuclei expressed cells at low density only (Table 1). Probes for Dhh and Ihh, the other two members of the Hedgehog (Hh) family (Briscoe and Therond 2013) did not generate significant signals in adjacent brain sections by RNAscope: one dot per nucleus was occasionally observed with both probes as shown in the cerebral cortex, hippocampus, and in the tuberal region of the hypothalamus (Fig. 1D–I).
Table 1
Distribution of Shh transcripts in the mouse brain
Region
Nucleus
  
Cortex
Layer I
 
1+
 
Layer II/III
 
1+–3+
 
Layer IV
 
1+–2+
 
Layer V
 
1+–3+
 
Layer VIa
 
1+–3+
 
Layer VIb
 
1+–3+
 
Claustrum
 
1+–4+
Hippocampus
CA1
 
1+–3+
 
CA2
 
1+–3+
 
CA3
 
1+–3+
 
Dentate gyrus
  
  
Granul cell layer
1+–3+
  
Polymorph layer
1+–2+
  
Molecular layer
1+–2+
Striatum
Caudate putamen
 
1+–4+
 
Anterior amygdala area
 
1+–4+
Pallidum
Globus pallidus
 
1+–4+
 
Magnocellular preoptic nucleus
 
1+–4+
 
Medial septal nucleus
 
1+–3+
 
Lateral septal nucleus
 
1+–4+
Thalamus
Medial habenular nucleus
 
1+
 
Lateral habenular nucleus
 
1+–3+
 
Paraventricular nucleus
 
1+–3+
 
Mediodorsal nucleus
 
1+–3+
 
Intermediodorsal nucleus
 
1+–3+
 
Centrolateral nucleus
 
1+–3+
 
Paracentral nucleus
 
1+–2+
 
Central medial nucleus
 
1+–3+
 
Lateral posterior nucleus
 
1+–3+
 
Dorsolateral geniculate nucleus
 
1+
 
Lateral dorsal nucleus
 
1+
 
Posterior nucleus
 
1+–3+
 
Ventral nucleus
  
  
Antero-lateral
1+–2+
  
Postero-lateral
1+
  
Medial
1+–3+
  
Postero-medial
1+–2+
 
Reticular nucleus
 
1+
 
Rhomboid nucleus
 
1+–3+
 
Submedius nucleus
 
1+–3+
 
Xiphoid nucleus
 
1+–2+
 
Reuniens nucleus
 
1+–2+
 
Ventral reuniens nucleus
 
1+–2+
Hypothalamus
Arcuate hypothalamic nucleus
  
  
Dorsal part
1+–3+
  
Ventral part
1+–3+
 
Ventromedial hypothalamic nucleus
  
  
Dorsomedial part
1+–3+
  
Central part
1+–3+
  
Ventromedial part
1+–3+
 
Dorsomedial hypothalamic nucleus
 
1+–3+
 
Posterior hypothalamic nucleus
 
1+–3+
 
Lateral hypothalamic nucleus
  
  
Anterior
1+–3+
  
Posterior
1+–3+
 
Median eminence
 
1+
 
Tuberal nucleus
 
1+–2+
 
Anterior hypothalamic nucleus
 
1+–2+
 
Sub-paraventricular zone
 
1+–3+
 
Paraventricular hypothalamic nucleus
 
1+–3+
 
Suprachiasmatic nucleus
 
1+
 
Optic chiasma
 
1+
 
Mammillary body
 
1+–3+
Midbrain
Ventral tegmental area
 
1+–3+
 
Substantia nigra, pars compacta
 
1+–3+
 
Substantia nigra, pars reticulata
 
1+–3+
Pons
Mesencephalic trigeminal nucleus
 
1+–4+
 
Pontine central gray
 
1+–3+
 
Motor trigeminal nucleus
 
1+–4+
Medulla
Facial nucleus
 
1+–4+
 
Intermediate reticular nucleus
 
1+–3+
 
Gigantocellular reticular nucleus
 
1+–3+
 
Parapyramidal nucleus
 
1+–2+
Cerebellum
Granule cell layer
 
1+
 
Purkinje cell layer
 
4+
 
Molecular layer
 
1+
 
White matter
 
1+
Density of Shh mRNA was estimated by smfISH from N = 3–4 animals. 4 + : very high density, > 30 dots/cell; 3 + : high density, 10–30 dots/cell; 2 + : moderate density, 6–9 dots/cell; 1 + : low density, 2–5 dots/cell. Nuclei associated to one dot were observed scattered in all regions. Shh-transcript expression was considered as “undetectable” in these cells

Shh mRNA is present in cells expressing neuronal and oligodendroglial markers

Further phenotyping of Shh mRNA-expressing cells in the mouse brain indicated that most of these cells were positive for the neuronal marker HuC/D, as shown in the cerebral cortex (Fig. 2A, B), the hippocampus (Fig. 2C) and the tuberal region of the hypothalamus (Fig. 2D), and recapitulated in Table 2. In the cortex and hypothalamus, activation of Shh signaling results in a different modulation of Gli1-3 in astrocytes (Tirou et al. 2021). Detailed analysis of Shh mRNA expression in HuC/D-positive cells revealed that in the hypothalamus, 34.0 ± 3.2% of neurons were positive for Shh transcripts in the ARC, 72.8 ± 4.3% in the VMH, and 42.5 ± 0.3% in the DMH (Fig. 2E, Table 3); whereas in the cerebral cortex, 29.6 ± 3.3% of the neurons (Table 3) expressed Shh mRNA. In the hypothalamus, Shh mRNA density was moderate to high in 4%–6% of ARC and DMH HuC/D-positive neurons and in 25% of VMH neurons (Fig. 2E). We also identified high Shh mRNA expression in GABAergic, cholinergic, nitrergic, and dopaminergic cells, as shown below and summarized in Tables 2 and 3. In the cerebral cortex, 95 ± 0.5% of the cells expressing Shh mRNA were HuC/D neurons (data not shown). Shh mRNA was also identified in a restricted cell population expressing the oligodendroglial markers Sox10 or/and Olig2 in all brain regions, as shown in the hippocampus (Fig. 3A, B) and in hypothalamic regions (Fig. 3C, D), in the globus pallidus and preoptic area (Fig. 3E, F), and in the dopaminergic region of the midbrain, including the ventral tegmental area (VTA), substantia nigra pars compacta (SNc) and reticulata (SNr) (Fig. 3G). Shh mRNA was undetectable in cells expressing the astroglial marker S100β as shown in the hippocampus (Fig. 4A) and in the tuberal region of the hypothalamus (Fig. 4B). Characterization of the microglial marker Aif1 by smfISH on adult mouse brain sections revealed intense signals associated with scattered nuclei in brain regions, as shown in hypothalamic nuclei (Fig. 4C), in agreement with the distribution of IBA1-positive microglial cells (Lier et al. 2021). Shh mRNA was not identified in microglial cells expressing Aif1 transcripts, as shown in the hypothalamus (Fig. 4C).
Table 2
Distribution of Shh transcripts in the neuronal population of the mouse brain
Region
Nucleus
HuC/D
Gad67
ChAT
nNOS
TH
Cortex
Layer I
1+
1+
0+
1+
n.d
 
Layer II/III
1+–3+
1+–3+
0+
1+–2+
n.d
 
Layer IV
1+–2+
1+
0+
1+
n.d
 
Layer V
1+–3+
1+–3+
0+
1+–3+
n.d
 
Layer VIa
1+–3+
1+–2+
0+
1+–3+
n.d
 
Layer VIb
1+–3+
1+–2+
0+
1+
n.d
Hippocampus
CA1
1+–3+
1+–3+
/
1+
n.d
 
CA2
1+–3+
1+–3+
/
1+
n.d
 
CA3
1+–3+
1+–3+
/
1+–3+
n.d
 
Dentate gyrus
     
 
Granul cell layer
1+–3+
/
/
1+
n.d
 
Polymorph layer
1+–2+
1+–2+
/
1+
n.d
 
Molecular layer
1+–2+
1+–2+
/
1+
n.d
Striatum
Caudate putamen
1+–3+
1+–3+
0+
n.d
n.d
Pallidum
Globus pallidus
n.d
1+–4+
0+
n.d
n.d
 
Magnocellular preoptic nucleus
n.d
1+–4+
1+–3+
n.d
n.d
Hypothalamus
Arcuate hypothalamic nucleus
     
 
Dorsal part
1+–3+
1+–3+
1+
1+–3+
n.d
 
Ventral part
1+–3+
1+–3+
1+
1+–2+
n.d
 
Ventromedial hypothalamic nucleus
     
 
Dorsomedial part
1+–3+
1+–3+
1+
1+–3+
n.d
 
Central part
1+–3+
1+
1+
1+–3+
n.d
 
Ventromedial part
1+–3+
1+
/
1+–3+
n.d
 
Dorsomedial hypothalamic nucleus
1+–3+
1+–3+
1+
1+–3+
n.d
 
Posterior hypothalamic nucleus
1+–3+
1+–3+
1+
1+
n.d
 
Lateral hypothalamic nucleus
     
 
Anterior
n.d
1+–3+
/
n.d
n.d
 
Posterior
1+–3+
1+–3+
0+
1+–3+
n.d
 
Posterior
1+–3+
1+–3+
0+
1+–3+
n.d
 
Median eminence
1+–2+
0+
/
0+
n.d
 
Tuberal nucleus
1+–2+
1+–2+
0+
1+
n.d
 
Anterior hypothalamic nucleus
n.d
1+–2+
/
n.d
n.d
 
Sub-paraventricular zone
n.d
1+–3+
/
n.d
n.d
 
Paraventricular hypothalamic nucleus
n.d
1+–2+
/
n.d
n.d
 
Suprachiasmatic nucleus
n.d
1+
/
n.d
n.d
 
Optic chiasma
n.d
/
/
n.d
n.d
Midbrain
Ventral tegmental area
n.d
n.d
n.d
n.d
1+–3+
 
Substantia nigra, pars compacta
n.d
n.d
n.d
n.d
1+–3+
 
Substantia nigra, pars reticulata
n.d
n.d
n.d
n.d
/
Pons
Mesencephalic trigeminal nucleus
n.d
1 + 
4+
1+–3+
n.d
 
Pontine central gray
n.d
1+–3+
1+–3+
1+–3+
n.d
 
Motor trigeminal nucleus
n.d
1+–2+
4+
/
n.d
Medulla
Facial nucleus
n.d
1+–2+
4+
1+–3+
n.d
 
Intermediate reticular nucleus
n.d
1+–2+
/
1+–3+
n.d
 
Gigantocellular reticular nucleus
n.d
1+–3+
/
1+–3+
n.d
 
Parapyramidal nucleus
n.d
1+
/
/
n.d
Cerebellum
Granule cell layer
n.d
1+
/
0+
n.d
 
Purkinje cell layer
n.d
4+
/
/
n.d
 
Molecular layer
n.d
1+
/
1+
n.d
 
White matter
n.d
1+
/
/
n.d
Density of Shh mRNA was estimated by smfISH from N = 3–4 animals. 4 + : highest density, > 20 dots/cell; 3 + : high density, 10–20 dots/cell; 2 + : moderate density, 6–9 dots/cell; 1 + : low density, 2–5 dots/cell; 0 + : undetectable, 0–1 dot/cell; /: not relevant; n.d.: not determined
Table 3
Percentage of Shh transcripts expressing cells in HuC/D+, GABAergic Gad67+, and nitrergic nNOS+ neuronal populations of the mouse cortex and arcuate, ventromedial and dorsomedial hypothalamic nuclei
Region
Shh+ cells (% ± SEM)a
 
HuC/D
Gad67
nNOS
Cortex
29.6 ± 3.3
5.9 ± 0.6
1.8 ± 0.2
Hypothalamus
   
 Arcuate
34.0 ± 3.2
36.1 ± 5.8
28.1 ± 3.7
 Ventromedial hypothalamic nucleus
72.8 ± 4.3
n.d
56.4 ± 5.8
 Dorsomedial hypothalamic nucleus
42.5 ± 0.3
56.2 ± 7.1
37.6 ± 1.1
The percentage is reported as mean ± SEM and was estimated by smfISH from N = 3 animals. More than 100 cells were counted per animal in each of the region analyzed. n.d. not determined
aScattered ChAT+ cells expressing low Shh (1+) were observed in the arcuate, ventromedial hypothalamic nucleus, and the dorsomedial hypothalamic nucleus

Shh mRNA is expressed in ChAT cholinergic neurons

Shh mRNA expression in ChAT-expressing neurons in the adult mouse brain is shown in Table 2. Shh smfISH associated with the neuronal marker ChAT revealed a very high density of Shh transcripts in ChAT-positive cholinergic neurons located in the trigeminal mesencephalic and motor nuclei and in the facial nucleus (Fig. 5A–D), consistent with their expression in motor neurons, as previously reported (Traiffort et al. 1998, 1999, 2001). In addition, a moderate to high density distribution of Shh mRNA was observed in cholinergic neurons scattered in the pontine central gray (Fig. 5A, B), in the magnocellular preoptic nucleus of the pallidum (Fig. 5E, G; Table 2). Shh transcripts were also distributed at low density in ChAT-positive neurons located in hypothalamic nuclei, including the ARC, dorsomedial, and central parts of the VMH, DMH, and posterior hypothalamic nucleus (Fig. 5H; Table 2). Shh transcripts were undetectable in cholinergic neurons distributed in different layers of the cerebral cortex (Fig. 5I), in the caudate putamen and globus pallidus (Fig. 5F), or in the posterior part of the lateral hypothalamic nucleus or tuberal nucleus (Table 2).

Shh mRNA is expressed in Gad67 GABAergic neurons

The expression of Shh mRNA in Gad67 GABAergic neurons in the adult mouse brain is reported in Table 2. Very high density of Shh transcripts in Gad67-expressing cells was observed in the pallidum (Fig. 5E–G) and in the Purkinje cell layer of the cerebellum in agreement with their expression in Purkinje cells (Fig. 6A). A high number of Shh+Gad67+ neurons were identified in the globus pallidus and the adjacent magnocellular preoptic nucleus (Fig. 5E–G), whereas a more limited number was present in hypothalamic nuclei such as in the ARC, the VMH and the DMH (Fig. 6B) and in more anterior hypothalamic nuclei (Fig. 6D). Moderate to high density of Shh mRNA was also identified in scattered GABAergic neurons located in the CA1–CA3 pyramidal cell layers of the hippocampus (Fig. 6E), in the polymorph and molecular layer of the dentate gyrus, and in layers II/III, V, VIa and VIb of the cerebral cortex (Fig. 6F), in the caudate putamen (Fig. 5E–G), in the pontine central gray (Fig. 5B), in the motor trigeminal and facial nuclei, and also in the intermediate and gigantocellular reticular nuclei (Fig. 5D). Low density of Shh mRNA was also detected in Gad67+ cells located throughout brain regions (Figs. 5A–D, 6B, D–F and Table 2). Quantification of Shh mRNA expression indicated that 36 ± 6% of GABAergic neurons were Shh+ in the ARC and 56 ± 7% in the DMH (Fig. 6C; Table 3); while in the cerebral cortex 6 ± 1% of Gad67+ neurons were expressing Shh transcripts (Table 3), with a total of 24 ± 3% of the cells expressing Shh mRNA being Gad67+ GABAergic neurons (data not shown). Shh mRNA was also evidenced in Gad67+ neurons in the VMH (Table 2) that occasionally populate this nucleus (Hrabovszky et al. 2012).

Shh mRNA is expressed in nNOS nitrergic neurons

Shh mRNA expression in nNOS-expressing neurons in the adult mouse brain is shown in Table 2. Shh smfISH combined with the nNOS marker identified consistent and robust expression of Shh mRNA in nitrergic neurons located in different brain areas. A moderate to high density of Shh transcripts was observed in cells located in the mesencephalic trigeminal nucleus and pontine central gray (Fig. 7A, B), in the intermediate reticular and gigantocellular nuclei, and in the facial nucleus in the medulla (Fig. 7C–E), in the CA3 pyramidal cell layer of the hippocampus, suggesting their expression in pyramidal neurons (Fig. 8A, A2), in various hypothalamic nuclei such as the ARC, VMH, DMH (Fig. 8B, C) and the posterior part of the lateral hypothalamic nucleus, and in cortical layers II/III, V, and VIa (Fig. 9A–A1). In the above regions, a low density of Shh mRNA was also detected in scattered cells expressing nNOS. We also identified a low density of Shh transcripts in nitrergic cells in hippocampal sparse cells located in the CA1 and CA2 pyramidal cell layers and in the dentate gyrus (Fig. 8A–A1), in the molecular layer of the cerebellum (Fig. 9B–D), in the tuberal and posterior hypothalamic nuclei of the hypothalamus (Fig. 8B–C), and in layers I, IV, and VIb of the cerebral cortex (Fig. 9A, A2). Quantification of Shh mRNA expression indicates that 28 ± 4% of nitrergic neurons are Shh+ in the ARC, 56 ± 6% in the VMH, and 38 ± 1% in the DMH (Fig. 8D; Table 3). In the cerebral cortex 1.8 ± 0.2% of nNOS+ neurons are Shh+ (Table 3) with a total of 6 ± 1.5% of the cells expressing Shh mRNA being nNOS+ nitrergic neurons.

Shh mRNA is expressed in tyrosine hydroxylase-expressing dopaminergic neurons

Shh mRNA expression in the hindbrain dopaminergic neurons is shown in Table 2. Shh smfISH combined with immunofluorescence of the neuronal tyrosine hydroxylase (TH) marker revealed a broad distribution of Shh mRNA in dopaminergic neurons in both the VTA and SNc (Fig. 10A, C), in agreement with a previous report based on a reporter mouse line (Gonzalez-Reyes et al. 2012; Turcato et al. 2022). Detailed analysis indicated that almost all TH-positive neurons expressed Shh transcripts at low to high density in the VTA (98 ± 6%) and in the SNc (97 ± 4%). Interestingly, a large proportion of TH-positive dopaminergic neurons expressed a high density of Shh mRNA (44 ± 6% in the VTA and 40 ± 3% in the SNc) (Fig. 10A, C–E). Shh smfISH combined with Ptc revealed co-expression of the Shh receptor with Shh in TH-positive neurons. However, the highest expression of Ptc was identified in scattered cells surrounding TH neurons in both the VTA and the SNc (Fig. 10A–D). SmfISH of Ptc and Smo, combined with immunofluorescence of the astroglial marker S100β, revealed that these cells were astrocytes and also expressed the Hh signaling pathway transducer Smo (Fig. 10F–I).

Discussion

Here, by further exploring the brain distribution of Shh, Dhh, and Ihh transcripts using smfISH (Tirou et al. 2020), we identified much broader expression of Shh mRNA than originally reported; whereas, Dhh and Ihh signals were not detectable (see summary Fig. 11A–D). Our current data unequivocally identify Shh transcripts in various populations of neurons as well as in a restricted population of oligodendroglial cells, both distributed in almost all brain regions. Astrocytes have been proposed as the major Shh-responsive cells in the adult rodent brain (Garcia et al. 2010, 2018; Ruat et al. 2015; Allahyari et al. 2019; Hill et al. 2019; Tirou et al. 2021; Wang et al. 2021). Thus, Shh synthesized and released by these neuronal and oligodendroglial cells is expected to regulate Hh signaling in astrocytes in these regions. We unequivocally identified Shh mRNA in GABAergic (Gad67+), cholinergic (ChAT+), nitrergic (nNOS+), and dopaminergic (TH+) neurons, and suggest its expression in other populations of neurons, including glutamatergic neurons in the cerebral cortex and in hypothalamic nuclei. These results are in agreement with previous reports describing Shh-transcript expression in GABAergic, cholinergic, dopaminergic, and some glutamatergic neurons using digoxigenin-labeled riboprobes (Traiffort et al. 1998; Traiffort et al. 2001; Charytoniuk et al. 2002; Lai et al. 2003; Machold et al. 2003; Loulier et al. 2006; Angot et al. 2008; Desouza et al. 2011; Ihrie et al. 2011; Ferent et al. 2013a; Eitan et al. 2016; Sanchez and Armstrong 2018; Sanchez et al. 2018; Gonzalez-Reyes et al. 2019; Rivell et al. 2019) or reporter lines (Garcia et al. 2010; Ihrie et al. 2011; Sanchez et al. 2018). Our present work identifies for the first time to our knowledge, Shh expression in nNOS neurons in several brain regions including the cerebral cortex, hippocampus and hypothalamus. Interestingly, neuronal Shh expression occurs at different levels of intensity, suggesting that Shh signals are tightly regulated in these cells. We also extend our previous observation of oligodendroglial Shh by reporting the presence of Shh mRNA in cells expressing the oligodendroglial markers Sox10 or/and Olig2 in all brain regions.
nNOS is responsible for the production of the radical gas nitric oxide (NO), which can act as an autocrine or paracrine messenger. Among the transduction pathways triggered by NO, activation of guanylate cyclase initiates transcription of various genes involved in multiple physiological processes, including modulation of synaptic transmission. A link between Shh signaling and NO has been established by a series of observations reporting that cGMP analogs increase the Shh differentiation response on chick neuronal explants (Robertson et al. 2001) while reduced NO levels in immature granule cell precursors (GCPs) of the outer granule cell layer during postnatal cerebellar development increase Ptc expression and impair GCP migration (Haag et al. 2012). The expression of Hedgehog-interacting protein (Hip), a negative regulator of Shh, in nNOS-positive neurons in the rodent brain (Loulier et al. 2005) also argues for a close regulation between NO and Shh signals. The presence of Shh transcripts in nNOS neurons suggests that, in these cells, Shh signals may be under the control of nNOS activity. Interestingly, the interaction of nNOS with Sox2 in the nucleus has been proposed to promote neuronal Shh transcription and to protect neurons from glutamate-induced excitotoxicity (Zhang et al. 2016). Alternatively, Shh may regulate nNOS activity through its action on local astrocytic Hh signaling and the release of glutamate and ATP factors, as demonstrated in cerebellar astrocytes (Okuda et al. 2016). Whether NO controls Shh transcription, synthesis, secretion, or degradation and whether Shh production attenuates or exacerbates the neurotoxicity associated with excessive NO production deserves further investigation.
In cerebral cortical layers, nNOS neurons have been divided into two types of inhibitory GABAergic neurons based on the intensity of nNOS immunoreactivity and NADPH diaphorase staining. Type 1 cells express high levels of nNOS immunoreactivity and NADPH diaphorase activity, are mainly found in layers V and VI (Oermann et al. 1999; Vercelli et al. 2000; Wiencken and Casagrande 2000; Barbosa et al. 2001; Lee and Jeon 2005; Perrenoud et al. 2012) and correspond mainly to projection neurons activated during sleep (Gerashchenko et al. 2008; Tricoire and Vitalis 2012). In our study, they may correspond to cells that express the highest level of nNOS mRNA and express little Shh mRNA (Fig. 9A, A2).
Type II cells correspond to a more heterogeneous population of neurons distributed throughout the mouse cortical layers, exhibiting low nNOS immunoreactivity and diaphorase activity (Lee and Jeon 2005; Perrenoud et al. 2012). They classically correspond to small- to medium-sized neurons with less characterized functions and also include neurogliaform interneurons mediating inhibitory GABAergic effects on pyramidal cells (Karagiannis et al. 2009; Olah et al. 2009). In our study, type II cells may correspond to cells expressing a lower level of nNOS mRNA (Fig. 9A, A1). Interestingly, the intensity of Shh mRNA is low to high in these cells.
In the hippocampus, the distribution of Shh+nNOS+ cells scattered throughout the hippocampal layers is in agreement with the distribution of nitrergic interneurons identified by NADPH diaphorase staining or immunohistochemistry (Tricoire and Vitalis 2012). Whether Shh mRNA is expressed in different types of nNOS interneurons, including VIP, calretinin, parvalbumin, or somatostatin interneurons, needs further investigation. The presence of nNOS mRNA identified in our study in the CA3 pyramidal field is in agreement with the network of nNOS-immunoreactive neurons in the rat (Chong et al. 2019) and in the mouse (Cork et al. 1998).
In the hypothalamus, we observed that the broad distribution of nNOS identified here by smfISH is very similar to that reported by immunohistochemistry (Chachlaki et al. 2017). Interestingly, our analyses of double-labeled structures highlight that Shh and nNOS mRNAs are abundantly co-expressed in hypothalamic nuclei, consistent with a potential role for NO signaling in modulating Shh activity. In DMH and VMH, it has been reported that 85% of nNOS-immunoreactive neurons are glutamatergic while less than 15% are GABAergic (Chachlaki et al. 2017). Thus, our data support that Shh is expressed in a large population of glutamatergic neurons as 38–56% of nNOS-positive neurons in these nuclei also express Shh mRNA. However, the Shh GABAergic neurons observed in the ARC, VMH, and DMH are also consistent with Shh expression in nNOS-positive cells, which are almost all GABAergic in the ARC (Chachlaki et al. 2017). Shh was not expressed in the few cholinergic neurons that populate these nuclei. Further studies, such as single-cell RNA sequencing, to access the molecular identity of hypothalamic Shh cell types are needed to identify which groups of GABAergic and glutamatergic neurons these cells belong to in these nuclei (Campbell et al. 2017) and in the LHA (Mickelsen et al. 2019; Rossi et al. 2019).
What are the physiological functions mediated by Shh ligand in hypothalamus? Recently, genetic activation of Shh signaling in mouse hypothalamic astrocytes has been shown to increase sensitivity to blood glucose levels and to display a major role in counteracting metabolic defects associated with aging and obesity (Tirou et al. 2021). The broad expression of Shh transcripts in multiple hypothalamic neuronal populations identified here, together with the distribution of both the precursor and the aminoterminal active fragments of Shh in hypothalamic tissues (Tirou et al. 2021), suggest that Shh signaling in astrocytes may be regulated locally to control glucose metabolism.
In addition to being expressed in the above-mentioned nuclei, Shh is also abundantly expressed in other hypothalamic nuclei implicated in the regulation of energy homeostasis such as the lateral hypothalamic nucleus or the paraventricular nucleus (Chachlaki et al. 2017). However, the presence of Shh in GABAergic neurons in the suprachiasmatic nucleus (SCN) supports a role for the pathway in regulating circadian rhythm as recently proposed (Tu et al. 2023). Shh from these neurons may modulate Hh signaling pathway mRNAs that are altered in the SCN of Clock mutant mice (Wang et al. 2018) or the activity of the superior cervical ganglion to regulate Ptc transcription in the pineal gland (Borjigin et al. 1999).
Activation of Shh signaling through the injection of active Shh protein in rodent or primate models of Parkinson’s disease has been shown to preserve TH immunoreactive neurons in the SN and dopaminergic axons in the striatum, improving motor function (Dass et al. 2002; Tsuboi and Shults 2002; Dass et al. 2005). The source of Shh that could signal for mediating these effects in the mesostriatal system has been unclear. We now provide further evidence that a source of Shh is possibly dopamine neurons of the SNc and of the VTA since almost all of these neurons expressed Shh in the adult mouse brain. Indeed, expression of Shh transcripts were not detected by us in our first studies in rat using specific digoxigenin-labeled riboprobes (Traiffort et al. 1998, 1999) or in mouse (unpublished observations), and was not reported by others using reporter mouse lines (Ihrie et al. 2011). Shh protein has not been reported, to our knowledge, in dopaminergic neurons by immunohistochemistry in adult rodent brain using Shh antibodies (Machold et al. 2003; Ihrie et al. 2011; Ferent et al. 2013b). Consequently, the absence of protein expression analysis in this region makes it difficult to verify consistency between transcript density and protein, an observation that may also apply to other brain regions where Shh protein expression analysis is absent. However, evidence for Shh expression by all TH neurons was observed using X-Gal staining of sections from 3-month-old mice heterozygous for a conditional, gene expression tracer allele of Shh (Shh-nLacZC/+) (Gonzalez-Reyes et al. 2012). Thus, the apparent discrepancy among these reports may reflect different sensitivity of reporters, of the mouse line constructs and of antibodies used. Of interest, genetic ablation of Shh in TH-expressing neurons was associated with motor deficits that might have resulted from loss of dopaminergic, cholinergic and fast spiking GABAergic neurons (Gonzalez-Reyes et al. 2012). It was postulated that GDNF was implicated in the inhibition of Shh expression from dopaminergic neurons. Our present data also indicate the presence of Ptc on dopaminergic neurons that was not identified previously, suggesting a possible cell autonomous mode of Shh signaling on dopaminergic neurons. However, we show that astrocytes in the VTA and the SNc expressed high levels of Ptc and Smo transcripts suggesting that Shh signaling in astrocytes might participate in dopaminergic neurons regulation in the healthy brain and might be involved in the complex mechanisms underlying their loss during Parkinson’s disease (Kery et al. 2020).

Conclusion

Although the precise distribution of Shh peptides needs to be further investigated in the adult rodent brain, the present results reveal that the Shh molecule is expressed more widely than originally thought. The widespread neuronal distribution of Shh mRNA in GABAergic, cholinergic, dopaminergic, nitrergic, and probably glutamatergic neurons, and its restricted expression in a population of oligodendroglial cells in almost all areas of the brain, suggest that Shh is an important physiological cue for astrocytes, which are the major Shh-responsive cells in the brain. Thus, Shh from neuronal sources may act locally or after transport to act on specific astrocyte populations to mediate anti-inflammatory actions or regulate energy metabolism (Garcia 2021; Tirou et al. 2021). However, as the transcription factor Gli1 is not expressed in neurons, Shh could act on neuronal Ptc (Traiffort et al. 1999) through non-canonical signaling to regulate neuronal functions and potentially the expression of Shh and Shh regulators (Loulier et al. 2005; Allahyari et al. 2019). Future physiological studies should be undertaken to examine how Shh mRNA and peptides are regulated from neuronal and oligodendroglial sources in healthy and pathological states. Such studies could not only provide a better understanding of the functions of Shh signaling in normal and pathological states, but also identify new regulatory mechanisms that could be targets for new drugs.

Declarations

Conflict of interest

The authors have no conflicts of interest.

Ethics approval

All experimental procedures were performed in accordance with the Council Directive 2010/63EU of the European Parliament and were approved (project n°4558) by the French ethic committee.
Not applicable.
The authors give consent for publication.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

e.Med Neurologie

Kombi-Abonnement

Mit e.Med Neurologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes, den Premium-Inhalten der neurologischen Fachzeitschriften, inklusive einer gedruckten Neurologie-Zeitschrift Ihrer Wahl.

Weitere Produktempfehlungen anzeigen
Anhänge

Supplementary Information

Below is the link to the electronic supplementary material.
Literatur
Zurück zum Zitat Allahyari RV, Clark KL, Shepard KA, Garcia ADR (2019) Sonic hedgehog signaling is negatively regulated in reactive astrocytes after forebrain stab injury. Sci Rep 9:565PubMedPubMedCentralCrossRef Allahyari RV, Clark KL, Shepard KA, Garcia ADR (2019) Sonic hedgehog signaling is negatively regulated in reactive astrocytes after forebrain stab injury. Sci Rep 9:565PubMedPubMedCentralCrossRef
Zurück zum Zitat Alvarez-Buylla A, Ihrie RA (2014) Sonic hedgehog signaling in the postnatal brain. Semin Cell Dev Biol 33:105–111PubMedCrossRef Alvarez-Buylla A, Ihrie RA (2014) Sonic hedgehog signaling in the postnatal brain. Semin Cell Dev Biol 33:105–111PubMedCrossRef
Zurück zum Zitat Andreu-Cervera A, Catala M, Schneider-Maunoury S (2021) Cilia, ciliopathies and hedgehog-related forebrain developmental disorders. Neurobiol Dis 150:105236PubMedCrossRef Andreu-Cervera A, Catala M, Schneider-Maunoury S (2021) Cilia, ciliopathies and hedgehog-related forebrain developmental disorders. Neurobiol Dis 150:105236PubMedCrossRef
Zurück zum Zitat Angot E, Loulier K, Nguyen-Ba-Charvet KT, Gadeau AP, Ruat M, Traiffort E (2008) Chemoattractive activity of sonic hedgehog in the adult subventricular zone modulates the number of neural precursors reaching the olfactory bulb. Stem Cells 26:2311–2320PubMedCrossRef Angot E, Loulier K, Nguyen-Ba-Charvet KT, Gadeau AP, Ruat M, Traiffort E (2008) Chemoattractive activity of sonic hedgehog in the adult subventricular zone modulates the number of neural precursors reaching the olfactory bulb. Stem Cells 26:2311–2320PubMedCrossRef
Zurück zum Zitat Antonellis PJ, Engle SE, Brewer KM, Berbari NF (2021) The Hedgehog signaling pathway is expressed in the adult mouse hypothalamus and modulated by fasting. eNeuro 8 Antonellis PJ, Engle SE, Brewer KM, Berbari NF (2021) The Hedgehog signaling pathway is expressed in the adult mouse hypothalamus and modulated by fasting. eNeuro 8
Zurück zum Zitat Barbosa IM, Ferrante SM, Mandarim-De-Lacerda CA (2001) Role of nitric oxide synthase in the etiopathogenesis of hypertrophic pyloric stenosis in infants. J Pediatr (rio j) 77:307–312PubMed Barbosa IM, Ferrante SM, Mandarim-De-Lacerda CA (2001) Role of nitric oxide synthase in the etiopathogenesis of hypertrophic pyloric stenosis in infants. J Pediatr (rio j) 77:307–312PubMed
Zurück zum Zitat Borjigin J, Deng J, Wang MM, Li X, Blackshaw S, Snyder SH (1999) Circadian rhythm of patched1 transcription in the pineal regulated by adrenergic stimulation and cAMP. J Biol Chem 274:35012–35015PubMedCrossRef Borjigin J, Deng J, Wang MM, Li X, Blackshaw S, Snyder SH (1999) Circadian rhythm of patched1 transcription in the pineal regulated by adrenergic stimulation and cAMP. J Biol Chem 274:35012–35015PubMedCrossRef
Zurück zum Zitat Briscoe J, Therond PP (2013) The mechanisms of Hedgehog signalling and its roles in development and disease. Nat Rev 14:416–429CrossRef Briscoe J, Therond PP (2013) The mechanisms of Hedgehog signalling and its roles in development and disease. Nat Rev 14:416–429CrossRef
Zurück zum Zitat Campbell EJ, Barker DJ, Nasser HM, Kaganovsky K, Dayas CV, Marchant NJ (2017) Cue-induced food seeking after punishment is associated with increased Fos expression in the lateral hypothalamus and basolateral and medial amygdala. Behav Neurosci 131:155–167PubMedPubMedCentralCrossRef Campbell EJ, Barker DJ, Nasser HM, Kaganovsky K, Dayas CV, Marchant NJ (2017) Cue-induced food seeking after punishment is associated with increased Fos expression in the lateral hypothalamus and basolateral and medial amygdala. Behav Neurosci 131:155–167PubMedPubMedCentralCrossRef
Zurück zum Zitat Chachlaki K, Malone SA, Qualls-Creekmore E, Hrabovszky E, Munzberg H, Giacobini P, Ango F, Prevot V (2017) Phenotyping of nNOS neurons in the postnatal and adult female mouse hypothalamus. J Comp Neurol 525:3177–3189PubMedPubMedCentralCrossRef Chachlaki K, Malone SA, Qualls-Creekmore E, Hrabovszky E, Munzberg H, Giacobini P, Ango F, Prevot V (2017) Phenotyping of nNOS neurons in the postnatal and adult female mouse hypothalamus. J Comp Neurol 525:3177–3189PubMedPubMedCentralCrossRef
Zurück zum Zitat Charytoniuk D, Porcel B, Rodriguez Gomez J, Faure H, Ruat M, Traiffort E (2002) Sonic Hedgehog signalling in the developing and adult brain. J Physiol Paris 96:9–16PubMedCrossRef Charytoniuk D, Porcel B, Rodriguez Gomez J, Faure H, Ruat M, Traiffort E (2002) Sonic Hedgehog signalling in the developing and adult brain. J Physiol Paris 96:9–16PubMedCrossRef
Zurück zum Zitat Chong PS, Poon CH, Fung ML, Guan L, Steinbusch HWM, Chan YS, Lim WL, Lim LW (2019) Distribution of neuronal nitric oxide synthase immunoreactivity in adult male Sprague-Dawley rat brain. Acta Histochem 121:151437PubMedCrossRef Chong PS, Poon CH, Fung ML, Guan L, Steinbusch HWM, Chan YS, Lim WL, Lim LW (2019) Distribution of neuronal nitric oxide synthase immunoreactivity in adult male Sprague-Dawley rat brain. Acta Histochem 121:151437PubMedCrossRef
Zurück zum Zitat Cork RJ, Perrone ML, Bridges D, Wandell J, Scheiner CA, Mize RR (1998) A web-accessible digital atlas of the distribution of nitric oxide synthase in the mouse brain. Prog Brain Res 118:37–50PubMedCrossRef Cork RJ, Perrone ML, Bridges D, Wandell J, Scheiner CA, Mize RR (1998) A web-accessible digital atlas of the distribution of nitric oxide synthase in the mouse brain. Prog Brain Res 118:37–50PubMedCrossRef
Zurück zum Zitat Dass B, Iravani MM, Jackson MJ, Engber TM, Galdes A, Jenner P (2002) Behavioural and immunohistochemical changes following supranigral administration of sonic hedgehog in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets. Neuroscience 114:99–109PubMedCrossRef Dass B, Iravani MM, Jackson MJ, Engber TM, Galdes A, Jenner P (2002) Behavioural and immunohistochemical changes following supranigral administration of sonic hedgehog in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets. Neuroscience 114:99–109PubMedCrossRef
Zurück zum Zitat Dass B, Iravani MM, Huang C, Barsoum J, Engber TM, Galdes A, Jenner P (2005) Sonic hedgehog delivered by an adeno-associated virus protects dopaminergic neurones against 6-OHDA toxicity in the rat. J Neural Transm (vienna) 112:763–778PubMedCrossRef Dass B, Iravani MM, Huang C, Barsoum J, Engber TM, Galdes A, Jenner P (2005) Sonic hedgehog delivered by an adeno-associated virus protects dopaminergic neurones against 6-OHDA toxicity in the rat. J Neural Transm (vienna) 112:763–778PubMedCrossRef
Zurück zum Zitat Del Giovane A, Russo M, Tirou L, Faure H, Ruat M, Balestri S, Sposato C, Basoli F, Rainer A, Kassoussi A, Traiffort E, Ragnini-Wilson A (2022) Smoothened/AMP-activated protein kinase signaling in oligodendroglial cell maturation. Front Cell Neurosci 15:17 Del Giovane A, Russo M, Tirou L, Faure H, Ruat M, Balestri S, Sposato C, Basoli F, Rainer A, Kassoussi A, Traiffort E, Ragnini-Wilson A (2022) Smoothened/AMP-activated protein kinase signaling in oligodendroglial cell maturation. Front Cell Neurosci 15:17
Zurück zum Zitat Desouza LA, Sathanoori M, Kapoor R, Rajadhyaksha N, Gonzalez LE, Kottmann AH, Tole S, Vaidya VA (2011) Thyroid hormone regulates the expression of the sonic hedgehog signaling pathway in the embryonic and adult Mammalian brain. Endocrinology 152:1989–2000PubMedPubMedCentralCrossRef Desouza LA, Sathanoori M, Kapoor R, Rajadhyaksha N, Gonzalez LE, Kottmann AH, Tole S, Vaidya VA (2011) Thyroid hormone regulates the expression of the sonic hedgehog signaling pathway in the embryonic and adult Mammalian brain. Endocrinology 152:1989–2000PubMedPubMedCentralCrossRef
Zurück zum Zitat Farmer WT, Abrahamsson T, Chierzi S, Lui C, Zaelzer C, Jones EV, Bally BP, Chen GG, Theroux JF, Peng J, Bourque CW, Charron F, Ernst C, Sjostrom PJ, Murai KK (2016) Neurons diversify astrocytes in the adult brain through sonic hedgehog signaling. Science 351:849–854PubMedCrossRef Farmer WT, Abrahamsson T, Chierzi S, Lui C, Zaelzer C, Jones EV, Bally BP, Chen GG, Theroux JF, Peng J, Bourque CW, Charron F, Ernst C, Sjostrom PJ, Murai KK (2016) Neurons diversify astrocytes in the adult brain through sonic hedgehog signaling. Science 351:849–854PubMedCrossRef
Zurück zum Zitat Ferent J, Ruat M, Traiffort E (2013a) Investigation of the proteolipid protein promoter activity during demyelination and repair. Differentiation 85:182–189PubMedCrossRef Ferent J, Ruat M, Traiffort E (2013a) Investigation of the proteolipid protein promoter activity during demyelination and repair. Differentiation 85:182–189PubMedCrossRef
Zurück zum Zitat Ferent J, Zimmer C, Durbec P, Ruat M, Traiffort E (2013b) Sonic Hedgehog signaling is a positive oligodendrocyte regulator during demyelination. J Neurosci 33:1759–1772PubMedPubMedCentralCrossRef Ferent J, Zimmer C, Durbec P, Ruat M, Traiffort E (2013b) Sonic Hedgehog signaling is a positive oligodendrocyte regulator during demyelination. J Neurosci 33:1759–1772PubMedPubMedCentralCrossRef
Zurück zum Zitat Garcia AD, Petrova R, Eng L, Joyner AL (2010) Sonic hedgehog regulates discrete populations of astrocytes in the adult mouse forebrain. J Neurosci 30:13597–13608PubMedPubMedCentralCrossRef Garcia AD, Petrova R, Eng L, Joyner AL (2010) Sonic hedgehog regulates discrete populations of astrocytes in the adult mouse forebrain. J Neurosci 30:13597–13608PubMedPubMedCentralCrossRef
Zurück zum Zitat Garcia ADR, Han YG, Triplett JW, Farmer WT, Harwell CC, Ihrie RA (2018) The elegance of sonic hedgehog: emerging novel functions for a classic morphogen. J Neurosci 38:9338–9345PubMedPubMedCentralCrossRef Garcia ADR, Han YG, Triplett JW, Farmer WT, Harwell CC, Ihrie RA (2018) The elegance of sonic hedgehog: emerging novel functions for a classic morphogen. J Neurosci 38:9338–9345PubMedPubMedCentralCrossRef
Zurück zum Zitat Gerashchenko D, Wisor JP, Burns D, Reh RK, Shiromani PJ, Sakurai T, de la Iglesia HO, Kilduff TS (2008) Identification of a population of sleep-active cerebral cortex neurons. Proc Natl Acad Sci USA 105:10227–10232PubMedPubMedCentralCrossRef Gerashchenko D, Wisor JP, Burns D, Reh RK, Shiromani PJ, Sakurai T, de la Iglesia HO, Kilduff TS (2008) Identification of a population of sleep-active cerebral cortex neurons. Proc Natl Acad Sci USA 105:10227–10232PubMedPubMedCentralCrossRef
Zurück zum Zitat Gonzalez-Reyes LE, Verbitsky M, Blesa J, Jackson-Lewis V, Paredes D, Tillack K, Phani S, Kramer ER, Przedborski S, Kottmann AH (2012) Sonic hedgehog maintains cellular and neurochemical homeostasis in the adult nigrostriatal circuit. Neuron 75:306–319PubMedPubMedCentralCrossRef Gonzalez-Reyes LE, Verbitsky M, Blesa J, Jackson-Lewis V, Paredes D, Tillack K, Phani S, Kramer ER, Przedborski S, Kottmann AH (2012) Sonic hedgehog maintains cellular and neurochemical homeostasis in the adult nigrostriatal circuit. Neuron 75:306–319PubMedPubMedCentralCrossRef
Zurück zum Zitat Gonzalez-Reyes LE, Chiang CC, Zhang M, Johnson J, Arrillaga-Tamez M, Couturier NH, Reddy N, Starikov L, Capadona JR, Kottmann AH, Durand DM (2019) Sonic Hedgehog is expressed by hilar mossy cells and regulates cellular survival and neurogenesis in the adult hippocampus. Sci Rep 9:17402PubMedPubMedCentralCrossRef Gonzalez-Reyes LE, Chiang CC, Zhang M, Johnson J, Arrillaga-Tamez M, Couturier NH, Reddy N, Starikov L, Capadona JR, Kottmann AH, Durand DM (2019) Sonic Hedgehog is expressed by hilar mossy cells and regulates cellular survival and neurogenesis in the adult hippocampus. Sci Rep 9:17402PubMedPubMedCentralCrossRef
Zurück zum Zitat Haag D, Zipper P, Westrich V, Karra D, Pfleger K, Toedt G, Blond F, Delhomme N, Hahn M, Reifenberger J, Reifenberger G, Lichter P (2012) Nos2 inactivation promotes the development of medulloblastoma in Ptch1(+/-) mice by deregulation of Gap43-dependent granule cell precursor migration. PLoS Genet 8:e1002572PubMedPubMedCentralCrossRef Haag D, Zipper P, Westrich V, Karra D, Pfleger K, Toedt G, Blond F, Delhomme N, Hahn M, Reifenberger J, Reifenberger G, Lichter P (2012) Nos2 inactivation promotes the development of medulloblastoma in Ptch1(+/-) mice by deregulation of Gap43-dependent granule cell precursor migration. PLoS Genet 8:e1002572PubMedPubMedCentralCrossRef
Zurück zum Zitat Harwell CC, Parker PR, Gee SM, Okada A, McConnell SK, Kreitzer AC, Kriegstein AR (2012) Sonic hedgehog expression in corticofugal projection neurons directs cortical microcircuit formation. Neuron 73:1116–1126PubMedPubMedCentralCrossRef Harwell CC, Parker PR, Gee SM, Okada A, McConnell SK, Kreitzer AC, Kriegstein AR (2012) Sonic hedgehog expression in corticofugal projection neurons directs cortical microcircuit formation. Neuron 73:1116–1126PubMedPubMedCentralCrossRef
Zurück zum Zitat Hill SA, Blaeser AS, Coley AA, Xie Y, Shepard KA, Harwell CC, Gao WJ, Garcia ADR (2019) Sonic hedgehog signaling in astrocytes mediates cell-type-specific synaptic organization. Elife 8:e45545PubMedPubMedCentralCrossRef Hill SA, Blaeser AS, Coley AA, Xie Y, Shepard KA, Harwell CC, Gao WJ, Garcia ADR (2019) Sonic hedgehog signaling in astrocytes mediates cell-type-specific synaptic organization. Elife 8:e45545PubMedPubMedCentralCrossRef
Zurück zum Zitat Hrabovszky E, Wittmann G, Kallo I, Fuzesi T, Fekete C, Liposits Z (2012) Distribution of type 1 cannabinoid receptor-expressing neurons in the septal-hypothalamic region of the mouse: colocalization with GABAergic and glutamatergic markers. J Comp Neurol 520:1005–1020PubMedCrossRef Hrabovszky E, Wittmann G, Kallo I, Fuzesi T, Fekete C, Liposits Z (2012) Distribution of type 1 cannabinoid receptor-expressing neurons in the septal-hypothalamic region of the mouse: colocalization with GABAergic and glutamatergic markers. J Comp Neurol 520:1005–1020PubMedCrossRef
Zurück zum Zitat Ihrie RA, Shah JK, Harwell CC, Levine JH, Guinto CD, Lezameta M, Kriegstein AR, Alvarez-Buylla A (2011) Persistent sonic hedgehog signaling in adult brain determines neural stem cell positional identity. Neuron 71:250–262PubMedPubMedCentralCrossRef Ihrie RA, Shah JK, Harwell CC, Levine JH, Guinto CD, Lezameta M, Kriegstein AR, Alvarez-Buylla A (2011) Persistent sonic hedgehog signaling in adult brain determines neural stem cell positional identity. Neuron 71:250–262PubMedPubMedCentralCrossRef
Zurück zum Zitat Karagiannis A, Gallopin T, David C, Battaglia D, Geoffroy H, Rossier J, Hillman EM, Staiger JF, Cauli B (2009) Classification of NPY-expressing neocortical interneurons. J Neurosci 29:3642–3659PubMedPubMedCentralCrossRef Karagiannis A, Gallopin T, David C, Battaglia D, Geoffroy H, Rossier J, Hillman EM, Staiger JF, Cauli B (2009) Classification of NPY-expressing neocortical interneurons. J Neurosci 29:3642–3659PubMedPubMedCentralCrossRef
Zurück zum Zitat Kery R, Chen APF, Kirschen GW (2020) Genetic targeting of astrocytes to combat neurodegenerative disease. Neural Regen Res 15:199–211PubMedCrossRef Kery R, Chen APF, Kirschen GW (2020) Genetic targeting of astrocytes to combat neurodegenerative disease. Neural Regen Res 15:199–211PubMedCrossRef
Zurück zum Zitat Lai K, Kaspar BK, Gage FH, Schaffer DV (2003) Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo. Nat Neurosci 6:21–27PubMedCrossRef Lai K, Kaspar BK, Gage FH, Schaffer DV (2003) Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo. Nat Neurosci 6:21–27PubMedCrossRef
Zurück zum Zitat Laouarem Y, Kassoussi A, Zahaf A, Hutteau-Hamel T, Mellouk A, Bobe P, Mattern C, Schumacher M, Traiffort E (2021) Functional cooperation of the hedgehog and androgen signaling pathways during developmental and repairing myelination. Glia 69:1369–1392PubMedCrossRef Laouarem Y, Kassoussi A, Zahaf A, Hutteau-Hamel T, Mellouk A, Bobe P, Mattern C, Schumacher M, Traiffort E (2021) Functional cooperation of the hedgehog and androgen signaling pathways during developmental and repairing myelination. Glia 69:1369–1392PubMedCrossRef
Zurück zum Zitat Lee JE, Jeon CJ (2005) Immunocytochemical localization of nitric oxide synthase-containing neurons in mouse and rabbit visual cortex and co-localization with calcium-binding proteins. Mol Cells 19:408–417PubMedCrossRef Lee JE, Jeon CJ (2005) Immunocytochemical localization of nitric oxide synthase-containing neurons in mouse and rabbit visual cortex and co-localization with calcium-binding proteins. Mol Cells 19:408–417PubMedCrossRef
Zurück zum Zitat Loulier K, Ruat M, Traiffort E (2005) Analysis of hedgehog interacting protein in the brain and its expression in nitric oxide synthase-positive cells. NeuroReport 16:1959–1962PubMedCrossRef Loulier K, Ruat M, Traiffort E (2005) Analysis of hedgehog interacting protein in the brain and its expression in nitric oxide synthase-positive cells. NeuroReport 16:1959–1962PubMedCrossRef
Zurück zum Zitat Loulier K, Ruat M, Traiffort E (2006) Increase of proliferating oligodendroglial progenitors in the adult mouse brain upon Sonic hedgehog delivery in the lateral ventricle. J Neurochem 98:530–542PubMedCrossRef Loulier K, Ruat M, Traiffort E (2006) Increase of proliferating oligodendroglial progenitors in the adult mouse brain upon Sonic hedgehog delivery in the lateral ventricle. J Neurochem 98:530–542PubMedCrossRef
Zurück zum Zitat Machold R, Hayashi S, Rutlin M, Muzumdar MD, Nery S, Corbin JG, Gritli-Linde A, Dellovade T, Porter JA, Rubin LL, Dudek H, McMahon AP, Fishell G (2003) Sonic hedgehog is required for progenitor cell maintenance in telencephalic stem cell niches. Neuron 39:937–950PubMedCrossRef Machold R, Hayashi S, Rutlin M, Muzumdar MD, Nery S, Corbin JG, Gritli-Linde A, Dellovade T, Porter JA, Rubin LL, Dudek H, McMahon AP, Fishell G (2003) Sonic hedgehog is required for progenitor cell maintenance in telencephalic stem cell niches. Neuron 39:937–950PubMedCrossRef
Zurück zum Zitat Malave L, Zuelke DR, Uribe-Cano S, Starikov L, Rebholz H, Friedman E, Qin C, Li Q, Bezard E, Kottmann AH (2021) Dopaminergic co-transmission with sonic hedgehog inhibits abnormal involuntary movements in models of Parkinson’s disease and l-Dopa induced dyskinesia. Commun Biol 4:1071PubMedPubMedCentralCrossRef Malave L, Zuelke DR, Uribe-Cano S, Starikov L, Rebholz H, Friedman E, Qin C, Li Q, Bezard E, Kottmann AH (2021) Dopaminergic co-transmission with sonic hedgehog inhibits abnormal involuntary movements in models of Parkinson’s disease and l-Dopa induced dyskinesia. Commun Biol 4:1071PubMedPubMedCentralCrossRef
Zurück zum Zitat McMahon AP, Ingham PW, Tabin CJ (2003) Developmental roles and clinical significance of hedgehog signaling. Curr Top Dev Biol 53:1–114PubMedCrossRef McMahon AP, Ingham PW, Tabin CJ (2003) Developmental roles and clinical significance of hedgehog signaling. Curr Top Dev Biol 53:1–114PubMedCrossRef
Zurück zum Zitat Mickelsen LE, Bolisetty M, Chimileski BR, Fujita A, Beltrami EJ, Costanzo JT, Naparstek JR, Robson P, Jackson AC (2019) Single-cell transcriptomic analysis of the lateral hypothalamic area reveals molecularly distinct populations of inhibitory and excitatory neurons. Nat Neurosci 22:642–656PubMedPubMedCentralCrossRef Mickelsen LE, Bolisetty M, Chimileski BR, Fujita A, Beltrami EJ, Costanzo JT, Naparstek JR, Robson P, Jackson AC (2019) Single-cell transcriptomic analysis of the lateral hypothalamic area reveals molecularly distinct populations of inhibitory and excitatory neurons. Nat Neurosci 22:642–656PubMedPubMedCentralCrossRef
Zurück zum Zitat Oermann E, Bidmon HJ, Mayer B, Zilles K (1999) Differential maturational patterns of nitric oxide synthase-I and NADPH diaphorase in functionally distinct cortical areas of the mouse cerebral cortex. Anat Embryol (berl) 200:27–41PubMedCrossRef Oermann E, Bidmon HJ, Mayer B, Zilles K (1999) Differential maturational patterns of nitric oxide synthase-I and NADPH diaphorase in functionally distinct cortical areas of the mouse cerebral cortex. Anat Embryol (berl) 200:27–41PubMedCrossRef
Zurück zum Zitat Okuda H, Tatsumi K, Morita-Takemura S, Nakahara K, Nochioka K, Shinjo T, Terada Y, Wanaka A (2016) Hedgehog signaling modulates the release of gliotransmitters from cultured cerebellar astrocytes. Neurochem Res 41:278–289PubMedCrossRef Okuda H, Tatsumi K, Morita-Takemura S, Nakahara K, Nochioka K, Shinjo T, Terada Y, Wanaka A (2016) Hedgehog signaling modulates the release of gliotransmitters from cultured cerebellar astrocytes. Neurochem Res 41:278–289PubMedCrossRef
Zurück zum Zitat Olah S, Fule M, Komlosi G, Varga C, Baldi R, Barzo P, Tamas G (2009) Regulation of cortical microcircuits by unitary GABA-mediated volume transmission. Nature 461:1278–1281PubMedPubMedCentralCrossRef Olah S, Fule M, Komlosi G, Varga C, Baldi R, Barzo P, Tamas G (2009) Regulation of cortical microcircuits by unitary GABA-mediated volume transmission. Nature 461:1278–1281PubMedPubMedCentralCrossRef
Zurück zum Zitat Pascual O, Traiffort E, Baker DP, Galdes A, Ruat M, Champagnat J (2005) Sonic hedgehog signalling in neurons of adult ventrolateral nucleus tractus solitarius. Eur J Neurosci 22:389–396PubMedCrossRef Pascual O, Traiffort E, Baker DP, Galdes A, Ruat M, Champagnat J (2005) Sonic hedgehog signalling in neurons of adult ventrolateral nucleus tractus solitarius. Eur J Neurosci 22:389–396PubMedCrossRef
Zurück zum Zitat Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxis coordinates. Academic Press, London Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxis coordinates. Academic Press, London
Zurück zum Zitat Perrenoud Q, Geoffroy H, Gauthier B, Rancillac A, Alfonsi F, Kessaris N, Rossier J, Vitalis T, Gallopin T (2012) Characterization of type I and type II nNOS-expressing interneurons in the barrel cortex of mouse. Front Neural Circuits 6:36PubMedPubMedCentralCrossRef Perrenoud Q, Geoffroy H, Gauthier B, Rancillac A, Alfonsi F, Kessaris N, Rossier J, Vitalis T, Gallopin T (2012) Characterization of type I and type II nNOS-expressing interneurons in the barrel cortex of mouse. Front Neural Circuits 6:36PubMedPubMedCentralCrossRef
Zurück zum Zitat Porcu G, Serone E, De Nardis V, Di Giandomenico D, Lucisano G, Scardapane M, Poma A, Ragnini-Wilson A (2015) Clobetasol and halcinonide act as smoothened agonists to promote myelin gene expression and RxRgamma receptor activation. PLoS ONE 10:e0144550PubMedPubMedCentralCrossRef Porcu G, Serone E, De Nardis V, Di Giandomenico D, Lucisano G, Scardapane M, Poma A, Ragnini-Wilson A (2015) Clobetasol and halcinonide act as smoothened agonists to promote myelin gene expression and RxRgamma receptor activation. PLoS ONE 10:e0144550PubMedPubMedCentralCrossRef
Zurück zum Zitat Reifenberger J, Wolter M, Weber RG, Megahed M, Ruzicka T, Lichter P, Reifenberger G (1998) Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 58:1798–1803PubMed Reifenberger J, Wolter M, Weber RG, Megahed M, Ruzicka T, Lichter P, Reifenberger G (1998) Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 58:1798–1803PubMed
Zurück zum Zitat Rivell A, Petralia RS, Wang YX, Clawson E, Moehl K, Mattson MP, Yao PJ (2019) Sonic hedgehog expression in the postnatal brain. Biol Open 8:040592 Rivell A, Petralia RS, Wang YX, Clawson E, Moehl K, Mattson MP, Yao PJ (2019) Sonic hedgehog expression in the postnatal brain. Biol Open 8:040592
Zurück zum Zitat Robertson CP, Gibbs SM, Roelink H (2001) cGMP enhances the sonic hedgehog response in neural plate cells. Dev Biol 238:157–167PubMedCrossRef Robertson CP, Gibbs SM, Roelink H (2001) cGMP enhances the sonic hedgehog response in neural plate cells. Dev Biol 238:157–167PubMedCrossRef
Zurück zum Zitat Rossi MA, Basiri ML, McHenry JA, Kosyk O, Otis JM, van den Munkhof HE, Bryois J, Hubel C, Breen G, Guo W, Bulik CM, Sullivan PF, Stuber GD (2019) Obesity remodels activity and transcriptional state of a lateral hypothalamic brake on feeding. Science 364:1271–1274PubMedPubMedCentralCrossRef Rossi MA, Basiri ML, McHenry JA, Kosyk O, Otis JM, van den Munkhof HE, Bryois J, Hubel C, Breen G, Guo W, Bulik CM, Sullivan PF, Stuber GD (2019) Obesity remodels activity and transcriptional state of a lateral hypothalamic brake on feeding. Science 364:1271–1274PubMedPubMedCentralCrossRef
Zurück zum Zitat Ruat M, Hoch L, Faure H, Rognan D (2014) Targeting of Smoothened for therapeutic gain. Trends Pharmacol Sci 35:237–246PubMedCrossRef Ruat M, Hoch L, Faure H, Rognan D (2014) Targeting of Smoothened for therapeutic gain. Trends Pharmacol Sci 35:237–246PubMedCrossRef
Zurück zum Zitat Ruat M, Faure H, Daynac M (2015) Smoothened, stem cell maintenance and brain diseases. Top Med Chem 16:147–171CrossRef Ruat M, Faure H, Daynac M (2015) Smoothened, stem cell maintenance and brain diseases. Top Med Chem 16:147–171CrossRef
Zurück zum Zitat Samanta J, Grund EM, Silva HM, Lafaille JJ, Fishell G, Salzer JL (2015) Inhibition of Gli1 mobilizes endogenous neural stem cells for remyelination. Nature 526:448–452PubMedPubMedCentralCrossRef Samanta J, Grund EM, Silva HM, Lafaille JJ, Fishell G, Salzer JL (2015) Inhibition of Gli1 mobilizes endogenous neural stem cells for remyelination. Nature 526:448–452PubMedPubMedCentralCrossRef
Zurück zum Zitat Sanchez MA, Armstrong RC (2018) Postnatal Sonic hedgehog (Shh) responsive cells give rise to oligodendrocyte lineage cells during myelination and in adulthood contribute to remyelination. Exp Neurol 299:122–136PubMedCrossRef Sanchez MA, Armstrong RC (2018) Postnatal Sonic hedgehog (Shh) responsive cells give rise to oligodendrocyte lineage cells during myelination and in adulthood contribute to remyelination. Exp Neurol 299:122–136PubMedCrossRef
Zurück zum Zitat Sanchez MA, Sullivan GM, Armstrong RC (2018) Genetic detection of Sonic hedgehog (Shh) expression and cellular response in the progression of acute through chronic demyelination and remyelination. Neurobiol Dis 115:145–156PubMedCrossRef Sanchez MA, Sullivan GM, Armstrong RC (2018) Genetic detection of Sonic hedgehog (Shh) expression and cellular response in the progression of acute through chronic demyelination and remyelination. Neurobiol Dis 115:145–156PubMedCrossRef
Zurück zum Zitat Swiderska-Syn M, Mir-Pedrol J, Oles A, Schleuger O, Salvador AD, Greiner SM, Seward C, Yang F, Babcock BR, Shen C, Wynn DT, Sanchez-Mejias A, Gershon TR, Martin V, McCrea HJ, Lindsey KG, Krieg C, Rodriguez-Blanco J (2022) Noncanonical activation of GLI signaling in SOX2(+) cells drives medulloblastoma relapse. Sci Adv 8:eabj9138PubMedPubMedCentralCrossRef Swiderska-Syn M, Mir-Pedrol J, Oles A, Schleuger O, Salvador AD, Greiner SM, Seward C, Yang F, Babcock BR, Shen C, Wynn DT, Sanchez-Mejias A, Gershon TR, Martin V, McCrea HJ, Lindsey KG, Krieg C, Rodriguez-Blanco J (2022) Noncanonical activation of GLI signaling in SOX2(+) cells drives medulloblastoma relapse. Sci Adv 8:eabj9138PubMedPubMedCentralCrossRef
Zurück zum Zitat Tirou L, Russo M, Faure H, Pellegrino G, Sharif A, Ruat M (2020) C9C5 positive mature oligodendrocytes are a source of Sonic Hedgehog in the mouse brain. PLoS ONE 15:e0229362PubMedPubMedCentralCrossRef Tirou L, Russo M, Faure H, Pellegrino G, Sharif A, Ruat M (2020) C9C5 positive mature oligodendrocytes are a source of Sonic Hedgehog in the mouse brain. PLoS ONE 15:e0229362PubMedPubMedCentralCrossRef
Zurück zum Zitat Tirou L, Russo M, Faure H, Pellegrino G, Demongin C, Daynac M, Sharif A, Amosse J, Le Lay S, Denis R, Luquet S, Taouis M, Benomar Y, Ruat M (2021) Sonic Hedgehog receptor patched deficiency in astrocytes enhances glucose metabolism in mice. Mol Metab 47:101172PubMedPubMedCentralCrossRef Tirou L, Russo M, Faure H, Pellegrino G, Demongin C, Daynac M, Sharif A, Amosse J, Le Lay S, Denis R, Luquet S, Taouis M, Benomar Y, Ruat M (2021) Sonic Hedgehog receptor patched deficiency in astrocytes enhances glucose metabolism in mice. Mol Metab 47:101172PubMedPubMedCentralCrossRef
Zurück zum Zitat Traiffort E, Charytoniuk DA, Faure H, Ruat M (1998) Regional distribution of Sonic Hedgehog, patched, and smoothened mRNA in the adult rat brain. J Neurochem 70:1327–1330PubMedCrossRef Traiffort E, Charytoniuk DA, Faure H, Ruat M (1998) Regional distribution of Sonic Hedgehog, patched, and smoothened mRNA in the adult rat brain. J Neurochem 70:1327–1330PubMedCrossRef
Zurück zum Zitat Traiffort E, Charytoniuk D, Watroba L, Faure H, Sales N, Ruat M (1999) Discrete localizations of hedgehog signalling components in the developing and adult rat nervous system. Eur J Neurosci 11:3199–3214PubMedCrossRef Traiffort E, Charytoniuk D, Watroba L, Faure H, Sales N, Ruat M (1999) Discrete localizations of hedgehog signalling components in the developing and adult rat nervous system. Eur J Neurosci 11:3199–3214PubMedCrossRef
Zurück zum Zitat Traiffort E, Moya KL, Faure H, Hassig R, Ruat M (2001) High expression and anterograde axonal transport of aminoterminal sonic hedgehog in the adult hamster brain. Eur J Neurosci 14:839–850PubMedCrossRef Traiffort E, Moya KL, Faure H, Hassig R, Ruat M (2001) High expression and anterograde axonal transport of aminoterminal sonic hedgehog in the adult hamster brain. Eur J Neurosci 14:839–850PubMedCrossRef
Zurück zum Zitat Traiffort E, Dubourg C, Faure H, Rognan D, Odent S, Durou MR, David V, Ruat M (2004) Functional characterization of sonic hedgehog mutations associated with holoprosencephaly. J Biol Chem 279:42889–42897PubMedCrossRef Traiffort E, Dubourg C, Faure H, Rognan D, Odent S, Durou MR, David V, Ruat M (2004) Functional characterization of sonic hedgehog mutations associated with holoprosencephaly. J Biol Chem 279:42889–42897PubMedCrossRef
Zurück zum Zitat Tricoire L, Vitalis T (2012) Neuronal nitric oxide synthase expressing neurons: a journey from birth to neuronal circuits. Front Neural Circuits 6:82PubMedPubMedCentralCrossRef Tricoire L, Vitalis T (2012) Neuronal nitric oxide synthase expressing neurons: a journey from birth to neuronal circuits. Front Neural Circuits 6:82PubMedPubMedCentralCrossRef
Zurück zum Zitat Tsuboi K, Shults CW (2002) Intrastriatal injection of sonic hedgehog reduces behavioral impairment in a rat model of Parkinson’s disease. Exp Neurol 173:95–104PubMedCrossRef Tsuboi K, Shults CW (2002) Intrastriatal injection of sonic hedgehog reduces behavioral impairment in a rat model of Parkinson’s disease. Exp Neurol 173:95–104PubMedCrossRef
Zurück zum Zitat Tu HQ, Li S, Xu YL, Zhang YC, Li PY, Liang LY, Song GP, Jian XX, Wu M, Song ZQ, Li TT, Hu HB, Yuan JF, Shen XL, Li JN, Han QY, Wang K, Zhang T, Zhou T, Li AL, Zhang XM, Li HY (2023) Rhythmic cilia changes support SCN neuron coherence in circadian clock. Science 380:972–979PubMedCrossRef Tu HQ, Li S, Xu YL, Zhang YC, Li PY, Liang LY, Song GP, Jian XX, Wu M, Song ZQ, Li TT, Hu HB, Yuan JF, Shen XL, Li JN, Han QY, Wang K, Zhang T, Zhou T, Li AL, Zhang XM, Li HY (2023) Rhythmic cilia changes support SCN neuron coherence in circadian clock. Science 380:972–979PubMedCrossRef
Zurück zum Zitat Turcato FC, Wegman E, Lu T, Ferguson N, Luo Y (2022) Dopaminergic neurons are not a major Sonic hedgehog ligand source for striatal cholinergic or PV interneurons. iScience 25:105278PubMedPubMedCentralCrossRef Turcato FC, Wegman E, Lu T, Ferguson N, Luo Y (2022) Dopaminergic neurons are not a major Sonic hedgehog ligand source for striatal cholinergic or PV interneurons. iScience 25:105278PubMedPubMedCentralCrossRef
Zurück zum Zitat Vercelli A, Garbossa D, Biasiol S, Repici M, Jhaveri S (2000) NOS inhibition during postnatal development leads to increased ipsilateral retinocollicular and retinogeniculate projections in rats. Eur J Neurosci 12:473–490PubMedCrossRef Vercelli A, Garbossa D, Biasiol S, Repici M, Jhaveri S (2000) NOS inhibition during postnatal development leads to increased ipsilateral retinocollicular and retinogeniculate projections in rats. Eur J Neurosci 12:473–490PubMedCrossRef
Zurück zum Zitat Wallace VA (1999) Purkinje-cell-derived Sonic hedgehog regulates granule neuron precursor cell proliferation in the developing mouse cerebellum. Curr Biol 9:445–448PubMedCrossRef Wallace VA (1999) Purkinje-cell-derived Sonic hedgehog regulates granule neuron precursor cell proliferation in the developing mouse cerebellum. Curr Biol 9:445–448PubMedCrossRef
Zurück zum Zitat Wang Y, Lv K, Zhao M, Liang F, Chen H, Ji G, Wang T, Zhang Y, Cao H, Li Y, Qu L (2018) Expression profiles and functional annotation analysis of mRNAs in suprachiasmatic nucleus of Clock mutant mice. Gene 647:107–114PubMedCrossRef Wang Y, Lv K, Zhao M, Liang F, Chen H, Ji G, Wang T, Zhang Y, Cao H, Li Y, Qu L (2018) Expression profiles and functional annotation analysis of mRNAs in suprachiasmatic nucleus of Clock mutant mice. Gene 647:107–114PubMedCrossRef
Zurück zum Zitat Wang H, Xu Z, Xia Z, Rallo M, Duffy A, Matise MP (2021) Inactivation of Hedgehog signal transduction in adult astrocytes results in region-specific blood-brain barrier defects. Proc Natl Acad Sci USA 118:e2017779118PubMedPubMedCentralCrossRef Wang H, Xu Z, Xia Z, Rallo M, Duffy A, Matise MP (2021) Inactivation of Hedgehog signal transduction in adult astrocytes results in region-specific blood-brain barrier defects. Proc Natl Acad Sci USA 118:e2017779118PubMedPubMedCentralCrossRef
Zurück zum Zitat Wiencken AE, Casagrande VA (2000) The distribution of NADPH diaphorase and nitric oxide synthetase (NOS) in relation to the functional compartments of areas V1 and V2 of primate visual cortex. Cereb Cortex 10:499–511PubMedCrossRef Wiencken AE, Casagrande VA (2000) The distribution of NADPH diaphorase and nitric oxide synthetase (NOS) in relation to the functional compartments of areas V1 and V2 of primate visual cortex. Cereb Cortex 10:499–511PubMedCrossRef
Zurück zum Zitat Wolter M, Reifenberger J, Sommer C, Ruzicka T, Reifenberger G (1997) Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 57:2581–2585PubMed Wolter M, Reifenberger J, Sommer C, Ruzicka T, Reifenberger G (1997) Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 57:2581–2585PubMed
Zurück zum Zitat Zhang Y, Beachy PA (2023) Cellular and molecular mechanisms of Hedgehog signalling. Nat Rev 24:668–687CrossRef Zhang Y, Beachy PA (2023) Cellular and molecular mechanisms of Hedgehog signalling. Nat Rev 24:668–687CrossRef
Zurück zum Zitat Zhang D, Wang H, Liu H, Tao T, Wang N, Shen A (2016) nNOS translocates into the nucleus and interacts with Sox2 to protect neurons against early excitotoxicity via promotion of Shh transcription. Mol Neurobiol 53:6444–6458PubMedCrossRef Zhang D, Wang H, Liu H, Tao T, Wang N, Shen A (2016) nNOS translocates into the nucleus and interacts with Sox2 to protect neurons against early excitotoxicity via promotion of Shh transcription. Mol Neurobiol 53:6444–6458PubMedCrossRef
Metadaten
Titel
Characterization of Sonic Hedgehog transcripts in the adult mouse brain: co-expression with neuronal and oligodendroglial markers
verfasst von
Mariagiovanna Russo
Giuliana Pellegrino
Hélène Faure
Linda Tirou
Ariane Sharif
Martial Ruat
Publikationsdatum
08.02.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Brain Structure and Function / Ausgabe 3/2024
Print ISSN: 1863-2653
Elektronische ISSN: 1863-2661
DOI
https://doi.org/10.1007/s00429-023-02756-2

Weitere Artikel der Ausgabe 3/2024

Brain Structure and Function 3/2024 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.